£515.00

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India

Price data last checked 136 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 7 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 86 days • 86 data points (No recent data available)

Historical
Generating forecast...
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 02 November 2025 23 November 2025 14 December 2025 04 January 2026 26 January 2026

Price Distribution

Price distribution over 86 days • 1 price levels

Days at Price
86 days 0 22 43 65 86 £515 Days at Price

Price Analysis

Most common price: £515 (86 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 86 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China
99% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India

£515.00 24 Feb 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States
97% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States

£520.00 10 Jan 2026
The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City
97% match

The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City

£795.00 04 Feb 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India

£515.00 12 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India

£515.00 24 Jan 2026
Glioblastoma - New Solutions for Brain Cancerogenesis (Oncology)
97% match

Glioblastoma - New Solutions for Brain Cancerogenesis (Oncology)

IntechOpen

£119.00 12 Apr 2026
The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City
97% match

The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City

£795.00 12 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States

£520.00 12 Jan 2026
Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)
97% match

Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)

Humana

£68.79 09 Mar 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 12 Mar 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 26 Feb 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 10 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 09 Apr 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan
96% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments
96% match

The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 06 Jan 2026
Genetic and Epigenetic Alterations in Patients with Malignant Glioma
96% match

Genetic and Epigenetic Alterations in Patients with Malignant Glioma

LAP Lambert Academic Publishing

£70.00 24 Feb 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India

£515.00 25 Jan 2026
IntechOpen - Novel Therapeutic Concepts in Targeting Glioma
96% match

IntechOpen - Novel Therapeutic Concepts in Targeting Glioma

IntechOpen

£137.87 18 Apr 2026
The 2023-2028 Outlook for Gamified Healthcare Solutions in the United States
96% match

The 2023-2028 Outlook for Gamified Healthcare Solutions in the United States

£520.00 30 Jan 2026
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments
96% match

The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 11 Jan 2026